QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
On November 7-10, 2024, while attending the Annual Meeting of the Clinical Association of Genitourinary Surgeons at Stanford University, hosted by Stanford’s Chair of Urology, Dr. Eila Skinner, Dr. Catalona was inspired by a presentation given by Nobel Prize Laureate,…
In the Summer/Fall QUEST, our readers were introduced to a rising star in the opera firmament:Benjamin R. Sokol. This year, 2024, has been an exciting one for Benjamin as he was named a winner of the 2024 Opera Index Competition…
A new survey finds that the majority of American men have incorrect beliefs regarding prostate cancer screening which could keep them from getting screened. In August, the American Cancer Society and the Harris Poll surveyed 1,200 US men ages 45…
This study looked at the effectiveness and safety of using MRI screening to detect prostate cancer in men aged 50-60. Researchers divided participants into two groups: one had systematic biopsies (where the prostate gland is charted into six regions and…
A recent article published in the Journal of the American Medical Association, Oncology (JAMA Oncol) included a report on the role of diet in men with low-risk prostate cancer. Dr. Stephen DeVries, a preventive cardiologist and Executive Director of the…
The study investigated how body mass index (BMI) relates to prostate cancer screening results, incidence, and mortality among men participating in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. This trial included 36,756 men who were regularly screened…
A recent clinical trial at Memorial Sloan Kettering Cancer Center in New York suggests that specific amounts of exercise before surgery among men with early-stage prostate cancer can improve two biomarkers associated with better outcomes. This study looked at…
The purpose of watchful waiting in prostate cancer is to avoid adverse effects of active treatment in men who are unlikely to experience long-term benefits of radical treatments due to their limited life expectancy. Is watchful waiting an appropriate management…
This study explores the use of active surveillance for patients with low-risk prostate cancer (LRPC) in Northern Italy. Active surveillance is a treatment strategy where patients are closely monitored instead of receiving immediate, aggressive treatment such as surgery or radiation….
In a phase-3 trial called VISION, researchers studied the effects of lutetium-177 [177Lu]Lu-PSMA-617 (vipivotide tetraxetan) in patients with metastatic castration-resistant prostate cancer. This treatment, when added to standard care, improved both radiographic progression-free survival and overall survival. The study also…
"*" indicates required fields
